EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 172 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,147 | -18.4% | 17,828 | +0.6% | 0.00% | – |
| Q2 2023 | $344,555 | -82.3% | 17,724 | -74.2% | 0.00% | -100.0% |
| Q1 2023 | $1,950,664 | -7.2% | 68,758 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $2,102,718 | +17.4% | 71,937 | +6.1% | 0.00% | 0.0% |
| Q3 2022 | $1,791,000 | -40.2% | 67,824 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $2,996,000 | -8.3% | 67,421 | +2.2% | 0.00% | 0.0% |
| Q1 2022 | $3,266,000 | -6.6% | 65,977 | -3.9% | 0.00% | 0.0% |
| Q4 2021 | $3,496,000 | -10.1% | 68,655 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $3,887,000 | -71.4% | 69,688 | -78.0% | 0.00% | -66.7% |
| Q2 2021 | $13,581,000 | +1.0% | 317,320 | -1.5% | 0.00% | -25.0% |
| Q1 2021 | $13,441,000 | -7.4% | 322,042 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $14,512,000 | -19.1% | 311,634 | -26.2% | 0.00% | -33.3% |
| Q3 2020 | $17,948,000 | -21.4% | 422,491 | -11.3% | 0.01% | -25.0% |
| Q2 2020 | $22,845,000 | +53.2% | 476,153 | +46.9% | 0.01% | +33.3% |
| Q1 2020 | $14,912,000 | -40.5% | 324,190 | -22.3% | 0.01% | -25.0% |
| Q4 2019 | $25,066,000 | +25.1% | 417,216 | +17.8% | 0.01% | +60.0% |
| Q3 2019 | $20,043,000 | -10.6% | 354,304 | -12.0% | 0.01% | -16.7% |
| Q2 2019 | $22,427,000 | +65.8% | 402,792 | +50.4% | 0.01% | +20.0% |
| Q1 2019 | $13,524,000 | +15.3% | 267,861 | -8.0% | 0.01% | +25.0% |
| Q4 2018 | $11,730,000 | -69.2% | 291,142 | -47.1% | 0.00% | -66.7% |
| Q3 2018 | $38,136,000 | +18.9% | 550,064 | +29.8% | 0.01% | +9.1% |
| Q2 2018 | $32,066,000 | +52.2% | 423,817 | +6.0% | 0.01% | +37.5% |
| Q1 2018 | $21,064,000 | -10.7% | 399,769 | -9.5% | 0.01% | -11.1% |
| Q4 2017 | $23,591,000 | -17.5% | 441,622 | -7.9% | 0.01% | -18.2% |
| Q3 2017 | $28,586,000 | -19.2% | 479,312 | +6.9% | 0.01% | 0.0% |
| Q2 2017 | $35,363,000 | +165.9% | 448,250 | +179.5% | 0.01% | +175.0% |
| Q1 2017 | $13,300,000 | +10.9% | 160,359 | +6.1% | 0.00% | 0.0% |
| Q4 2016 | $11,996,000 | +22.8% | 151,196 | +8.4% | 0.00% | +33.3% |
| Q3 2016 | $9,765,000 | +131.2% | 139,509 | +28.2% | 0.00% | +50.0% |
| Q2 2016 | $4,223,000 | -20.9% | 108,845 | -17.5% | 0.00% | 0.0% |
| Q1 2016 | $5,341,000 | -63.8% | 131,883 | -20.8% | 0.00% | -66.7% |
| Q4 2015 | $14,766,000 | +24.1% | 166,530 | +3.6% | 0.01% | +20.0% |
| Q3 2015 | $11,899,000 | +322.2% | 160,732 | +361.2% | 0.01% | +400.0% |
| Q2 2015 | $2,818,000 | +4106.0% | 34,853 | +2078.3% | 0.00% | – |
| Q1 2015 | $67,000 | +318.8% | 1,600 | +60.0% | 0.00% | – |
| Q4 2014 | $16,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |